Seeing Is Believing
Currently out of the existing stock ratings of Timur Ivannikov, 16 are a BUY (88.89%), 2 are a HOLD (11.11%).
Analyst Timur Ivannikov, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 80.95% that have a potential upside of 36.57% achieved within 313 days.
Timur Ivannikov’s has documented 29 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 05-May-2023.
Analyst best performing recommendations are on NE (NOBLE PLC).
The best stock recommendation documented was for NE (NOBLE PLC) at 11/15/2021. The price target of $21 was fulfilled within 11 days with a profit of $1.13 (5.11%) receiving and performance score of 4.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2026
$22
$3.44 (18.53%)
$25
4 months 6 days ago
(02-Mar-2026)
2/2 (100%)
$10.8 (96.43%)
152
Buy Since 25-Jun-2025
$32
$13.44 (72.41%)
$28
7 months 4 days ago
(04-Dec-2025)
0/3 (0%)
$19.01 (146.34%)
Buy Since 14-Jul-2025
$27
$8.44 (45.47%)
11 months 24 days ago
(14-Jul-2025)
0/1 (0%)
$14.2 (110.94%)
Buy Since 12-Nov-2021
$400
4 years 3 months 7 days ago
(31-Mar-2022)
1/1 (100%)
$204.75 (104.87%)
459
Hold
4 years 7 months 21 days ago
(16-Nov-2021)
1/1 (100%)
$-14.38 (-43.08%)
196
What Year was the first public recommendation made by Timur Ivannikov?